Back to search

Article

Distinct immune-effector and metabolic profile of CD8<sup>+</sup> T Cells in patients with autoimmune polyarthritis induced by therapy with immune-checkpoint inhibitors

2022-03-12

Abstract excerpt

<h4>Objectives</h4> Rheumatic immune-related adverse events (irAE) such as (poly)arthritis in patients undergoing immune checkpoint inhibitor (ICI) treatment pose a major clinical challenge. ICI-therapy improves CD8+ T cell (CD8) function, but CD8 contribute to chronic inflammation in autoimmune arthritis (AA). Thus, we studied whether immune-functional and metabolic changes in CD8 explain the development of muscu...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a7d6a507-12c9-5fb0-be28-51ca8292e6b0
DOI
10.1101/2022.03.09.22272158
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Distinct immune-effector and metabolic profile of CD8<sup>+</sup> T Cells in patients with autoimmune polyarthritis induced by therapy with immune-checkpoint inhibitorsDOI 10.1101/2022.03.09.22272158
Select a neighboring publication to make it the new centre.